CN105669787B - A method of extracting ring olivil 9- glucosides from Cortex Eucommiae - Google Patents

A method of extracting ring olivil 9- glucosides from Cortex Eucommiae Download PDF

Info

Publication number
CN105669787B
CN105669787B CN201610145086.6A CN201610145086A CN105669787B CN 105669787 B CN105669787 B CN 105669787B CN 201610145086 A CN201610145086 A CN 201610145086A CN 105669787 B CN105669787 B CN 105669787B
Authority
CN
China
Prior art keywords
water
glucosides
methanol
cortex eucommiae
ring olivil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610145086.6A
Other languages
Chinese (zh)
Other versions
CN105669787A (en
Inventor
康兴东
赵春超
陈子琦
吴永忠
邵建华
杨伟庆
陈佳
周朝忠
徐晓庆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangxi Puzheng Pharmaceutical Co., Ltd.
Original Assignee
PUZHENG PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PUZHENG PHARMACEUTICAL CO Ltd filed Critical PUZHENG PHARMACEUTICAL CO Ltd
Priority to CN201610145086.6A priority Critical patent/CN105669787B/en
Publication of CN105669787A publication Critical patent/CN105669787A/en
Application granted granted Critical
Publication of CN105669787B publication Critical patent/CN105669787B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification
    • C07H1/08Separation; Purification from natural products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A method of from 9 glucosides of Cortex Eucommiae extraction ring olivil, belonging to pharmaceutical technology field.The step of preparation method that ring olivil 4' glucosides is extracted in this Cortex Eucommiae, is followed successively by extraction, concentration, centrifugation, extraction, macroporous absorbent resin separation, silica gel column chromatography separation, the separation of ODS column chromatographies, the separation of MCI column chromatographies, the separation of 20 chromatographies of Sephadex LH, half prepares or preparative HPLC chromatographic isolation obtains 9 glucosides of ring olivil.Beneficial effects of the present invention:The present invention provides the extracting methods of 9 glucosides of Cortex Eucommiae middle ring olivil.This method has obtained 9 glucosides of ring olivil that purity is more than 98%.

Description

A method of extracting ring olivil 9- glucosides from Cortex Eucommiae
Technical field
The invention belongs to pharmaceutical technology fields, and in particular to Lignanoids compounds preparation method in Cortex Eucommiae.
Background technology
Cortex Eucommiae(Eucommia ulmoides Oliv.)For the dry bark of Eucommiaceae plant Cortex Eucommiae.Cortex Eucommiae is known as " living Phytolite ", medicinal history is long,《Sheng Nong's herbal classic》Be classified as top grade, call its " cure mainly waist and knee, bowl spares, strengthening the essence gas, Hard muscles and bones, except wet, dribbling urination of itching under the moon.Long term usage is made light of one's life by commiting suicide resistance to old." Cortex Eucommiae is the rare tonic Chinese herbal medicine of China's tradition, it is used for tonifying liver Kidney, strengthening the bones and muscles.
See that the chemical composition of document report includes lignanoids, iridoids, Phenylpropanoid Glycosides class, flavonoids etc. in Cortex Eucommiae About 200 chemical compositions altogether.Lignanoids compounds are most studies in chemical component of eucommia bark used, ingredient is most clear, structure is most clear Clear a kind of compound, separated obtain is double tetrahydrofuran class compound mostly.So far, it is separated from Cortex Eucommiae Lignanoids compounds to have 44, mostly glycosides compound, glycosyl be β-D-Glucose.Structure type is mostly bis-epoxy Lignanoid(Bisepoxylignans, i.e. double tetrahydrofuran class), such as Pinoresinol diglucoside, cloves fat diglucoside Deng other also a small amount of monocycle oxygen lignanoid(monoepoxylignans), neolignan(neolignans), sesquilignan (sesqiulignans)With ring lignanoid(cyclolignans)Deng.Have no the isolated ring olive resin from Cortex Eucommiae at present The relevant report of plain 9- glucosides.
Invention content
The purpose of the present invention is according to defect described above, providing, a kind of recovery rate is high to extract ring olive resin from Cortex Eucommiae The method of plain 9- glucosides.
Ring olivil 9- glucosides provided by the invention, has the following structure:
A kind of method of Cortex Eucommiae extraction ring olivil 9- glucosides, which is characterized in that pass sequentially through following steps preparation It obtains:
(1)Cortex Eucommiae is extracted using the ethyl alcohol or methanol of 50%-95% through solvent extraction method, extracting solution is recovered under reduced pressure, obtains and slightly carries Object;
(2)Take step(1)The crude extract of gained is centrifuged with being stood after distillation water dissolution, is taken supernatant;
(3)Take step(2)The supernatant petroleum ether extraction of gained discards petroleum ether extraction liquid, remaining aqueous solution decompression It is concentrated to give medicinal extract;
(4)Take step(3)The medicinal extract of gained is detached through macroporous absorbent resin, with the ethanol elution of distilled water and 70%-95%, Ethanol eluate is through being concentrated under reduced pressure to obtain ethanol elution object;
(5)Take step(4)The ethanol elution object of gained is detached through silica gel column chromatography, with chloroform/methanol mixed solvent ladder Degree elution;
(6)Take step(5)Middle gained flow point is detached through ODS column chromatographies, with methanol/water or ethanol/water mixed solvent ladder Degree elution;
(7)Take step(6)Middle gained flow point is detached through MCI column chromatographies, with methanol/water or ethanol/water mixed solvent ladder Degree elution;
(8)Take step(7)Middle gained flow point is detached through Sephadex LH-20 chromatographies, mixed with methanol/water or ethanol/water Bonding solvent elutes, and obtains ring olivil 9- glucosides crude products;
(9)Take step(8)Middle gained ring olivil 9- glucosides crude products are prepared through half or preparative HPLC chromatographic isolation, With methanol/water, acetonitrile/water or methanol/acetonitrile/water elute for mobile phase, obtain ring olivil 9- glucosides.
Step in the preparation method of ring olivil 9- glucosides provided by the invention(3)Petroleum ether and supernatant volume ratio It is 1:3~3:1, extraction times are 2~5 times.
Step in the preparation method of ring olivil 9- glucosides provided by the invention(4)When macroporous absorbent resin detaches, The w/v of medicinal extract and distilled water is 1:20~1:30;The w/v of medicinal extract and ethyl alcohol is 1:10~1:40.
Step in the preparation method of ring olivil 9- glucosides provided by the invention(5)Eluting solvent is 1:0~20:1 Chloroform/methanol.
Step in the preparation method of ring olivil 9- glucosides provided by the invention(6)Eluting solvent is 1:9~4:0 Methanol/water or ethanol/water.
Step in the preparation method of ring olivil 9- glucosides provided by the invention(7)Eluting solvent is 1:10~4:0 Methanol/water or ethanol/water.
Step in the preparation method of ring olivil 9- glucosides provided by the invention(8)Eluting solvent is 1:10~2:1 Methanol/water or ethanol/water.
Step in the preparation method of ring olivil 9- glucosides provided by the invention(9)Mobile phase is methanol/water, second Nitrile/water or methanol/acetonitrile/water are 1 from methanol/water mixed solvent ratio:10~1:0, acetonitrile/water mixed solvent ratio 1:20 ~1:Ring olivil 9- glucosides is obtained in 0 flow point.
The beneficial effects of the invention are as follows:The present invention provides the extracting methods of Cortex Eucommiae middle ring olivil 9- glucosides.It should Method has obtained the ring olivil 9- glucosides that purity is more than 98%, and recovery rate is high.
Specific implementation mode
The following examples will be further described the present invention, but not thereby limiting the invention.
Embodiment 1.
(1)Eucommia ulmoides 20kg, 95% ethyl alcohol being separately added into, heating and refluxing extraction 3 times 2 hours every time, are recovered under reduced pressure Extracting solution obtains alcohol extracts.
(2)Alcohol extracts add 50L distilled water, and 12 hours are stood after dissolving, and it is viscous to obtain brown after rotating speed 5000 rpm centrifugations Thick precipitation and clarified supernatant, tan precipitate discard.
(3)To step(2)Isometric petroleum ether is added in middle clarified supernatant, after fully stirring evenly, stands 12 hours, takes out Supernatant, then isometric petroleum ether is added into remaining clear solution, repetition aforesaid operations are secondary, and petroleum ether extraction liquid is abandoned It goes.Remaining clear solution is concentrated under reduced pressure, and obtains medicinal extract 2.2kg.
(4)Take step(3)Middle medicinal extract 2.2kg is detached through macroporous absorbent resin HPD 100, distills water elution, distillation with 50L Water elution discards.Then with 60 L, 95% ethanol elutions, eluent obtains ethanol elution object after reduced pressure.
(5)Take step(4)Middle ethanol elution object, detaches through silica gel column chromatography, uses chloroform:Methanol is respectively 1:0,20: 1,10:1,7:1,5:1,2:1,1:1 carries out gradient elution.
(6)Take step(5)In with chloroform:Methanol is 7:1 elution gained flow point, detaches through ODS column chromatographies, uses methanol: Water is respectively 1:9,1:4,2:3,3:2,4:1,1:0 carries out gradient elution.
(7)Take step(6)Middle methanol:Water is 1:4 elution gained flow points, detach through MCI column chromatographies, use methanol:Moisture It Wei 1:9,1:4,2:3,3:2,4:1,1:0 carries out gradient elution.
(8)Take step(7)Middle methanol:Water is 2:3 elution gained flow points, detach through Sephadex LH-20 column chromatographies, Use methanol:Water is 3:7 are eluted, and ring olivil 9- glucosides crude products are obtained.
(9)Ring olivil 9- glucosides crude product is through preparing HPLC chromatogram separation, with methanol:Water is 28:72 isocratic elutions, Flow velocity is 2ml/min, and ring olivil 4'- glucosides 2.15g, purity 98.3% are obtained within 18 minutes in retention time.
The Structural Identification data of ring olivil 9- glucosides are as follows:
White powder, Molisch reactions are positive, and sour water solution detects D-Glucose.IR (KBr) cm-1:3391, 2936,1605,1514,1450,1371,1256,1155,1076,1031,861,775,630,580,533. UV λmax (CH3OH) nm:207,284.HR ESI MSm/z: 561.1955 ([M+Na]+, C26H34NaO12, Calcd 561.1948), 573.1742 ([M+Cl]-, C26H34ClO12, Calcd 573.1739)。
1H NMR ( 600 MHz, MeOD) δ: 6.80 ( 1H, d, J =1.9 Hz, H-2), 6.76 (1H, d, J =7.9 Hz, H-5), 6.66 (1H, dd,J =1.9,7.9 Hz, H-6), 6.63 (1H, 3, H-2' ), 6.18 (H, s, H-5'), 4.12-4.15 (2H, m, 7,9-H), 4.07 (1H, d,J = 7.9 Hz, H- 1''), 3.85 (1H, d,J =11.3 Hz, H-9'), 3.81 (6H, s, 3,3'-OCH3 ), 3.54 (1H, d, J =11.3 Hz, H-9'), 3.45 (1H, dd,J =4.3,10.6 Hz, H-9), 3.26 (1H, d,J =16.6 Hz, H-7'), 2.61 (1H, d,J = 16.6 Hz, H-7' )。
13C NMR ( 150 MHz, MeOD) δ:149.1 (C-3), 147.5 (C-3'), 146.1 (C-4 ), 145.2 (C-4'), 138.2 (C-1), 133.5 (C-1'), 126.5 (C-6'), 123.4 (C- 6), 117.3 (C-5'), 116.2 (C-5), 114.4 (C-2), 113.0 (C-2'), 105.3 (C-1 "), 78.1 (C-3 "), 78.0 (C-5''), 75.1 (C-2''), 74.5 (C-8'), 71.5 (C-4''), 69.2 (C-9 ), 68.8 (C-9'), 62.6 (C-6''), 56.5 (- OCH3 ), 56.4 (- OCH3 ), 46.7 (C-8), 44.9 (C-7), 40.0 (C-7').
Embodiment 2.
(1)Eucommia ulmoides 100kg, 85% ethyl alcohol being separately added into, heating and refluxing extraction 3 times 2 hours every time, are recovered under reduced pressure Extracting solution obtains alcohol extracts.
(2)Alcohol extracts add 250L distilled water, and 12 hours are stood after dissolving, and it is viscous to obtain brown after rotating speed 5000 rpm centrifugations Thick precipitation and clarified supernatant, tan precipitate discard.
(3)To step(2)2 times of volume petroleum ethers are added in middle clarified supernatant, after fully stirring evenly, stands 12 hours, takes Go out supernatant, then isometric petroleum ether is added into remaining clear solution, repetition aforesaid operations are secondary, and petroleum ether extraction liquid is abandoned It goes.Remaining clear solution is concentrated under reduced pressure, and obtains medicinal extract 10.5kg.
(4)Take step(3)Middle medicinal extract 10.5kg is detached through macroporous absorbent resin HPD 100, is distilled water elution with 300L, is steamed Distilled water eluent discards.Then with 400 L, 95% ethanol elutions, eluent obtains ethanol elution object after reduced pressure.
(5)Take step(4)Middle ethanol elution object, detaches through silica gel column chromatography, uses chloroform:Methanol is respectively 20:1,7: 1,3:1,1:1 carries out gradient elution.
(6)Take step(5)In with chloroform:Methanol is 7:1 elution gained flow point, detaches through ODS column chromatographies, uses methanol: Water is respectively 1:9,1:4,2:3,4:1 carries out gradient elution.
(7)Take step(6)Middle methanol:Water is 1:4 elution gained flow points, detach through MCI column chromatographies, use methanol:Moisture It Wei 1:4,2:3,3:2,1:0 carries out gradient elution.
(8)Take step(7)Middle methanol:Water is 2:3 elution gained flow points, detach through Sephadex LH-20 column chromatographies, Use ethyl alcohol:Water is 2:3 are eluted, and ring olivil 9- glucosides crude products are obtained.
(9)Ring olivil 9- glucosides crude product is through preparing HPLC chromatogram separation, with acetonitrile:Water is 20:80 isocratic elutions, Flow velocity is 2ml/min, and ring olivil 9- glucosides 11.07g, purity 99.4% are obtained within 25 minutes in retention time.
The Structural Identification method of ring olivil 9- glucosides is the same as embodiment 1.

Claims (8)

1. a kind of method of Cortex Eucommiae extraction ring olivil 9- glucosides, which is characterized in that pass sequentially through following steps and be prepared into It arrives:
(1)Cortex Eucommiae is extracted using the ethyl alcohol or methanol of 50%-95% through solvent extraction method, extracting solution is recovered under reduced pressure, obtains crude extract;
(2)Take step(1)The crude extract of gained is centrifuged with being stood after distillation water dissolution, is taken supernatant;
(3)Take step(2)The supernatant petroleum ether extraction of gained, discards petroleum ether extraction liquid, and remaining aqueous solution is concentrated under reduced pressure Obtain medicinal extract;
(4)Take step(3)The medicinal extract of gained is detached through macroporous absorbent resin, with the ethanol elution of distilled water and 70%-95%, ethyl alcohol Eluent is through being concentrated under reduced pressure to obtain ethanol elution object;
(5)Take step(4)The ethanol elution object of gained is detached through silica gel column chromatography, is washed with chloroform/methanol mixed solvent gradient It is de-;
(6)Take step(5)Middle gained flow point is detached through ODS column chromatographies, is washed with methanol/water or ethanol/water mixed solvent gradient It is de-;
(7)Take step(6)Middle gained flow point is detached through MCI column chromatographies, is washed with methanol/water or ethanol/water mixed solvent gradient It is de-;
(8)Take step(7)Middle gained flow point is detached through Sephadex LH-20 chromatographies, molten with methanol/water or ethanol/water mixing Agent elutes, and obtains ring olivil 9- glucosides crude products;
(9)Take step(8)Middle gained ring olivil 9- glucosides crude products are prepared through half or preparative HPLC chromatographic isolation, with first Alcohol/water, acetonitrile/water or methanol/acetonitrile/water elute for mobile phase, obtain ring olivil 9- glucosides.
2. a kind of method of Cortex Eucommiae extraction ring olivil 9- glucosides according to claim 1, it is characterised in that:Step (3)Petrochina ether is 1 with supernatant volume ratio:3~3:1, extraction times are 2~5 times.
3. a kind of method of Cortex Eucommiae extraction ring olivil 9- glucosides according to claim 1, it is characterised in that:Step (4)When middle macroporous absorbent resin separation, the w/v of medicinal extract and distilled water is 1:20~1:30;The weight of medicinal extract and ethyl alcohol Volume ratio is 1:10~1:40.
4. a kind of method of Cortex Eucommiae extraction ring olivil 9- glucosides according to claim 1, it is characterised in that:Step (5)Middle eluting solvent is 1:0~20:1 chloroform/methanol.
5. a kind of method of Cortex Eucommiae extraction ring olivil 9- glucosides according to claim 1, it is characterised in that:Step (6)Middle eluting solvent is 1:9~4:0 methanol/water or ethanol/water.
6. a kind of method of Cortex Eucommiae extraction ring olivil 9- glucosides according to claim 1, it is characterised in that:Step (7)Middle eluting solvent is 1:10~4:0 methanol/water or ethanol/water.
7. a kind of method of Cortex Eucommiae extraction ring olivil 9- glucosides according to claim 1, it is characterised in that:Step (8)Middle eluting solvent is 1:10~2:1 methanol/water or ethanol/water.
8. a kind of method of Cortex Eucommiae extraction ring olivil 9- glucosides according to claim 1, it is characterised in that:Step (9)Middle mobile phase is methanol/water, acetonitrile/water or methanol/acetonitrile/water, and methanol/water mixed solvent ratio is 1:10~1:0, second Nitrile/water mixed solvent ratio 1:20~1:0.
CN201610145086.6A 2016-03-15 2016-03-15 A method of extracting ring olivil 9- glucosides from Cortex Eucommiae Active CN105669787B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610145086.6A CN105669787B (en) 2016-03-15 2016-03-15 A method of extracting ring olivil 9- glucosides from Cortex Eucommiae

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610145086.6A CN105669787B (en) 2016-03-15 2016-03-15 A method of extracting ring olivil 9- glucosides from Cortex Eucommiae

Publications (2)

Publication Number Publication Date
CN105669787A CN105669787A (en) 2016-06-15
CN105669787B true CN105669787B (en) 2018-10-09

Family

ID=56310659

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610145086.6A Active CN105669787B (en) 2016-03-15 2016-03-15 A method of extracting ring olivil 9- glucosides from Cortex Eucommiae

Country Status (1)

Country Link
CN (1) CN105669787B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106361798B (en) * 2016-08-18 2019-04-26 广东药科大学 A kind of extracting method of Resin glycoside class compound

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102526165A (en) * 2010-12-07 2012-07-04 中国医学科学院药物研究所 Rhodiola effective fractions, preparation method, drug composition and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102526165A (en) * 2010-12-07 2012-07-04 中国医学科学院药物研究所 Rhodiola effective fractions, preparation method, drug composition and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Chemical constituents fromStauntonia brachyanthera Hand–Mazz;Chao Chen et al.;《Biochemical Systematics and Ecology》;20130124;第48卷;182-185 *
New Chemical Constituents of Roots of Urtica triangularis HAND-MASS;Xing-Guo YAN et al.;《Chem. Pharm. Bull.》;20081031;第56卷(第10期);1463-1465 *

Also Published As

Publication number Publication date
CN105669787A (en) 2016-06-15

Similar Documents

Publication Publication Date Title
CN109776635B (en) Method for separating eight components in traditional Chinese medicine composition
CN112300242B (en) Preparation method of furostanol saponin compound monomer
CN105399656A (en) Isobenzazole alkaloid compound, and preparation method and applications thereof
CN109879844A (en) The extraction separation method of seven kinds of flavonoids in Sabia parviflora Wall.ex Roxb
CN110627861A (en) Anemarrhena steroid saponin compound and preparation method and application thereof
CN109320571B (en) Method for extracting luteolin compound and cynaropicrin
CN100453550C (en) Gen-seng saponin Rb2 preparation process
CN105669787B (en) A method of extracting ring olivil 9- glucosides from Cortex Eucommiae
CN106176782B (en) Application of chemical components of eclipta as phytoestrogen
CN105753916B (en) A method of extracting ring 4 '-glucosides of olivil from Cortex Eucommiae
Zhang et al. New 8-prenylated quercetin glycosides from the flowers of Epimedium acuminatum and their testosterone production-promoting activities
CN108586559B (en) Lanostane type triterpenoid compound and preparation method and application thereof
CN105031178A (en) Extracting refining method making efficient utilization of anemarrhena asphodeloides
CN109180622A (en) The method of guainane type sesquiterpenoid is extracted from globe artichoke
CN111303238B (en) Steroid saponin compound and preparation method and medical application thereof
Xing et al. A new pregnane-type glycoside from Reineckia carnea
CN105330588A (en) Novel alkaloid Oleracone in herba portulacae, and extraction separation method thereof
CN114249783B (en) Phenyl butanediamide glycoside compound and preparation method and application thereof
CN103880896B (en) Lithocarpus polystachyus (wall) Rehd separates novel dihydrochalcone glycosides compound and preparation method thereof
CN109678922B (en) Nortriterpenoid compound and preparation method and application thereof
CN115677816B (en) Novel furostanol saponin monomer and preparation method thereof
CN110003293B (en) Method for extracting parasitoside from Chinese rose
CN113372407B (en) Steroid saponin compound and preparation method and application thereof
CN114456191B (en) Extraction method and application of tocopherol derivatives of overground parts of Chinese yam
CN112592377B (en) Method for separating flavonoid chemical components from ginkgo leaf extract

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP03 Change of name, title or address

Address after: 343100 No. 5 Ji'an Avenue, Jinggangshan Economic and Technological Development Zone, Ji'an City, Jiangxi Province

Patentee after: Puzheng Pharmaceutical Group Co., Ltd.

Address before: 343000 Jinggangshan economic and Technological Development Zone, Ji'an, Jiangxi

Patentee before: Puzheng Pharmaceutical Co.,Ltd.

CP03 Change of name, title or address
TR01 Transfer of patent right

Effective date of registration: 20200423

Address after: 343100 Innovation Avenue 278, Jinggangshan Economic and Technological Development Zone, Ji'an City, Jiangxi Province

Patentee after: Jiangxi Puzheng Pharmaceutical Co., Ltd.

Address before: 343100 No. 5 Ji'an Avenue, Jinggangshan Economic and Technological Development Zone, Ji'an City, Jiangxi Province

Patentee before: PUZHENG PHARMACEUTICAL GROUP Co.,Ltd.

TR01 Transfer of patent right